Iridian Asset Management LLC Genprex, Inc. Transaction History

Iridian Asset Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$3.11 - $4.87 $178,318 - $279,231	-57,337 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$3.66 - $7.67 $209,853 - $439,774	57,337 New	57,337 $247,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.